Gen Digital Inc. — Form 10-Q Summary
Business context and reporting period. Gen Digital provides consumer cybersecurity, identity protection and online privacy services under brands including Norton, Avast, LifeLock, Avira, AVG and CCleaner. The filing covers the 13 weeks and 26 weeks ended September 29, 2023, Gen’s fiscal Q2 and first half of fiscal 2024. The prior-year comparison includes Avast only from its September 12, 2022 acquisition date, making the periods less directly comparable.
Financial performance and position
| Metric | Q2 FY2024 | Q2 FY2023 | Six months FY2024 | Six months FY2023 |
|---|---|---|---|---|
| Revenue | $948 million | $748 million | $1,894 million | $1,455 million |
| Gross profit / margin | $768 million / 81% | $629 million / 84% | $1,535 million / 81% | $1,234 million / 85% |
| Operating income | $25 million | $241 million | $387 million | $502 million |
| Net income | $149 million | $69 million | $338 million | $269 million |
| Diluted EPS | $0.23 | $0.12 | $0.52 | $0.45 |
| Operating cash flow | $125 million | $(88) million | $351 million | $127 million |
Q2 revenue rose 27%; first-half revenue rose 30%. Consumer security revenue was $604 million in Q2, up from $436 million, and identity and information protection revenue was $328 million, up from $298 million. Management attributed growth primarily to Avast’s contribution and higher sales in both product areas; foreign exchange reduced Q2 revenue by $7 million and first-half revenue by $16 million.
Cash flow and liquidity. Cash and cash equivalents were $629 million at September 29, down from $750 million at March 31. First-half investing cash flow was $3 million, versus $(6.546) billion in the prior-year period, which included the Avast acquisition. Financing cash flow was $(485) million, including $266 million of debt repayments, $164 million of dividends and $41 million of share repurchases. The company also had an undrawn $1.5 billion revolving facility. Current assets were $1.076 billion and current liabilities were $2.460 billion.
Debt. Principal debt totaled $9.633 billion ($9.508 billion net of discounts and issuance costs), including $7.026 billion of variable-rate term loans and $2.600 billion of senior notes. Q2 interest expense was $173 million, compared with $48 million; first-half interest expense was $343 million, compared with $79 million. A 100-basis-point increase in SOFR would add an estimated $70 million to annual interest expense, before considering hedges. Swaps fixed rates on $1 billion of Term A borrowings through March 2026. Gen reported covenant compliance at quarter-end.
Material changes and unusual items
- Operating income declined despite revenue growth. Gen cited a substantial increase in legal accruals and related fees, higher acquired-intangible amortization, and acquisition-related cost changes. Q2 general and administrative expense rose to $393 million from $110 million; the company attributed $340 million of the increase to legal accruals, including $335 million related to patent litigation and associated fees.
- Q2 income before tax was a loss of $141 million, but net income was $149 million because of a $290 million income tax benefit. The benefit included a $268 million benefit from an internal legal-entity and operational restructuring. Gen cautioned that final tax outcomes could materially affect future results.
- Cost of revenue rose faster than revenue, and gross margin fell to 81% from 84% in Q2. Acquired-intangible amortization and payment-processing fees were among the cited drivers.
- First-half cash and contract liabilities declined by $121 million and $116 million, respectively, from March 31. Management attributed the cash decline to interest and tax payments, dividends, debt repayments and repurchases; the contract-liability decline primarily reflected seasonal billings and foreign exchange.
Outlook, commentary and risks
Gen provided no specific numerical revenue or earnings guidance in the supplied filing text. Management said existing cash, operating cash generation and available revolving credit were expected to meet working-capital needs, ongoing activities, expected Avast synergy costs and known long-term contractual obligations for at least the next 12 months. The Avast-related restructuring plan is expected to be completed by the end of fiscal 2024, with total costs of up to $150 million; $102 million had been incurred by September 29.
The most significant disclosed contingency is the Columbia University patent case. After a $185 million jury award, the court entered judgment including enhanced damages of 2.6 times the award, interest, supplemental damages and attorneys’ fees. Gen accrued approximately $576 million, its current estimate of the low end of probable losses, posted a surety bond and appealed. The filing states that additional losses above the accrual are reasonably possible but not reasonably estimable.
Other notable exposures include the unresolved GSA matter, where plaintiffs sought to amend a judgment and Gen said additional loss is reasonably possible but not estimable; and ongoing regulatory and legal matters related to Avast’s former Jumpshot data practices, for which Gen could not assess a reasonably possible loss. Gen also highlighted competition, customer retention and conversion, cybersecurity and privacy regulation, integration and synergy execution, foreign exchange, inflation, interest rates and substantial debt as risks. Management noted that subscription revenue may delay the effect of macroeconomic changes.
Subsequent events included two $100 million voluntary Term B prepayments in October 2023, a $12 million net sale of Tucson property on October 12, and a $0.125-per-share dividend announced November 7 for payment in December.
Important facts for investors to verify
- Track the Columbia appeal, final damages and fees, and any cash or insurance recovery; compare outcomes with the $576 million accrual.
- Assess the sustainability of reported net income and the $290 million quarterly tax benefit, including the $268 million restructuring-related component and uncertain tax positions.
- Monitor operating margins, acquired-intangible amortization, legal expenses and whether Avast integration synergies offset costs.
- Review debt reduction, variable-rate exposure, interest costs, covenant headroom and cash available after dividends and other commitments.
- Follow the Jumpshot-related regulatory and litigation matters and the GSA plaintiffs’ motions, whose potential losses were not fully estimable.
- Consider the comparability impact of Avast’s acquisition timing and the reported customer metrics: direct customer count was 38.5 million versus 38.6 million year over year, while monthly direct ARPU was $7.28 versus $6.98.